Sectoral Asset Management

Sectoral Asset Management Inc. is an industry-leading specialist in managing global investment portfolios in the healthcare sector.

Business Model:

Revenue: $13.5M

Employees: 11-50

Rankings

Detailed Sectoral Asset Management Information

Geographic Data

Sectoral Asset Management headquarters map

Address: 1010 Sherbrooke St. West,

City: Montreal

State: quebec

Zip: H3A 2R7

Country: CA

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$96M

Metrics

5,356,779Website Global Rank

1,721Website Monthly Traffic

Twitter Followers

Description

Sectoral Asset Management Inc. is an industry-leading specialist in managing global investment portfolios in the healthcare sector. Sectoral maintains offices in Montreal and Geneva and is a proud member of the State Street Global Alliance. They currently manage approximately US $4.0 billion in assets.

Contact Phone:
+15148498777

Contact Email:

Announced Date Company Transaction Money Raised
4/2013 RainDance Technologies Series E 0
2/2023 Garuda Therapeutics Series B 0
11/2012 Endosense Series C 40.3M
9/2015 Intellia Therapeutics Series B 0
5/2022 Apnimed Series C 62.5M
12/2022 Apnimed Series C 79.7M
6/2015 Cogent Biosciences Series B 65M
6/2022 Mineralys Therapeutics Series B 0
7/2020 CurvaFix Series B 10.7M
1/2023 Miach Orthopaedics Series B 0
6/2020 Checkmate Pharmaceuticals Series C 85M
5/2020 Atea Series D 215M
11/2016 Shockwave Medical Series C 45M
6/2020 Prilenia Series A 62.5M
10/2021 Babylon Post-IPO Equity 0
8/2022 Iantrek Series B 23M
9/2021 Garuda Therapeutics Series A 72M
3/2009 BioVex Venture Round 40M
11/2018 Aprea Series C 0
2/2021 Pipeline Therapeutics Series C 0
8/2021 Effector Therapeutics Post-IPO Equity 0
7/2017 Effector Therapeutics Series C 38.6M
8/2017 Apellis Pharmaceuticals Series E 0
7/2021 Turnstone Biologics Series D 0
5/2015 Shockwave Medical Series B 40M
12/2019 Pipeline Therapeutics Series B 0
10/2009 Endosense Series B 0
5/2015 REGENXBIO Series D 0
2/2015 Advaxis Post-IPO Equity 0
5/2023 Boundless Bio Series C 0
3/2016 Aprea Series B 50.6M
2/2022 Magnolia Medical Technologies Venture Round 0
2/2016 Effector Therapeutics Series B 16M
6/2016 F2G Series E 60M
1/2023 Amolyt Pharma Series C 0
8/2015 Advaxis Post-IPO Equity 25M
10/2021 Better Therapeutics Post-IPO Equity 0
9/2021 Amolyt Pharma Series B 0
11/2013 Endosense Series C 41.2M
2/2021 Viracta Therapeutics Post-IPO Equity 65M
1/2021 Neuros Medical Series B 0
1/2019 HighLife Series B 36M
11/2021 Prilenia Series B 0
5/2018 Rainier Therapeutics Series B 20M
7/2017 Simplify Medical Series B 21M
2/2018 Simplify Medical Series B 23M
6/2022 Mineralys Therapeutics Series B 0
5/2022 Apnimed Series C 0
2/2022 Magnolia Medical Technologies Venture Round 0
11/2021 Prilenia Series B 0
10/2021 Better Therapeutics Post-IPO Equity 0
10/2021 Babylon Post-IPO Equity 0
9/2021 Garuda Therapeutics Series A 0
9/2021 Amolyt Pharma Series B 0
8/2021 Effector Therapeutics Post-IPO Equity 0
7/2021 Turnstone Biologics Series D 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research